Sleep Apnea Devices Market

ResMed (US) and Koninklijke Philips (Netherlands) are leading players Sleep Apnea Devices Market

The global sleep apnea devices market is projected to reach USD 7.5 billion by 2024 from USD 4.5 billion in 2019, at a CAGR of 10.7%. Growth in the sleep apnea devices market can be attributed to factors such as a large pool of undiagnosed sleep apnea patients, growing awareness about the ill effects of untreated sleep apnea, growing usage of oral appliances, technological advancements in sleep apnea devices, influx of venture capital funding, and the increasing number of companies venturing into sleep apnea and oral appliances markets. Also, there are growth opportunities for the market due to the increasing demand for home healthcare and increasing focus on telemedicine and mHealth (mobile Health). On the other hand, the high cost of CPAP machines and complex referral pathways & long waiting periods are expected to be the key factors that restrain market growth to a certain extent during the forecast year.

The major players in the sleep apnea devices market include ResMed (US), Koninklijke Philips (Netherlands), and Fisher & Paykel Healthcare (New Zealand). Analysis of the market developments between 2016 and 2019 revealed that several growth strategies such as partnerships & agreements, expansions, service launches, and strategic acquisitions were adopted by the market players to strengthen their product portfolios and maintain a competitive position in the sleep apnea devices market.

In 2018, ResMed (US) dominated the sleep apnea devices market. The company has a diversified product portfolio, widespread geographical presence, and focuses on strategies such as product launches and innovations. The company also focuses on launching technologically advanced products in order to maintain its leading position in the market. Additionally, ResMed has a broad product portfolio for sleep apnea disorders and offers a variety of devices and accessories. The company prominently operates in the Americas. It pursues business strategies such as product launches, approvals, enhancements, and acquisitions in order to sustain its position in the sleep apnea devices market. For instance, in 2019, ResMed launched the AirFit N30i, its first top-of-head-connected nasal CPAP mask. In 2018, ResMed upgraded its Astral life support ventilators, including its Optional AutoEPAP in iVAPS. In 2018, ResMed launched its QuietAir Diffuser Vent for CPAP masks, AirFit F20 with silicone cushion, and its AirTouch F20 with memory foam cushion. In 2019, ResMed acquired HB Healthcare, a home medical equipment provider, which offers sleep and respiratory care devices. Through this acquisition, ResMed extended its reach to patients through HBH and its wider network of trusted distributor partners.

To know about the assumptions considered for the study download the pdf brochure

In 2018, Koninklijke Philips (Netherlands) was the second largest player with a share of ~39%. The company’s wide geographical presence and strong distribution network have also helped it gain a significant market share. In the past three years, innovation has been the company’s core business strategy in order to increase its share in the sleep apnea devices market. This strategy is largely supported by the company’s strong R&D activities. Philips invested USD 2.07 billion in R&D activities in 2017. Philips’ rich pool of skilled R&D personnel ensures constant development and launch of technologically advanced products in the sleep apnea devices market. This further helps the company in launching products like masks, PAP devices, and ventilators in the market.

In 2018, Fisher & Paykel Healthcare (New Zealand) was the third largest player with a share of ~13%. The company employs multiple distribution channels to market its products in more than 120 countries. It employs a direct sales team in around 36 countries to sell its products directly to hospitals, long-term care facilities, and home healthcare dealers. The direct sales team enables the firm to have a dedicated focus on its products, rather than being present in the distributor’s portfolio with other companies.

The company invested 9.0%, 9.6%, and 9.7 % of its total revenue in 2015, 2016, and 2017, respectively, into R&D activities and introduced about five new products in the same period. Fisher & Paykel’s rich pool of skilled R&D personnel ensures constant development and introduction of technologically advanced products in the market.

Related Reports:

Sleep Apnea Devices Market by Type, (Therapeutic (CPAP, APAP, Masks, ASV, Oral Appliances, Mandibular Advancement Device)), Diagnostic (PSG, Oximeter), End User (Sleep Laboratories & Hospitals, Home Care Settings/Individuals) - Global Forecasts to 2024

Contact:
Mr. Shelly Singh
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441
sales@marketsandmarkets.com

Report Code
MD 1181
RI Published ON
5/15/2019
Choose License Type
BUY NOW
  • SHARE
X
Request Customization
Speak to Analyst
Speak to Analyst
OR FACE-TO-FACE MEETING
PERSONALIZE THIS RESEARCH
  • Triangulate with your Own Data
  • Get Data as per your Format and Definition
  • Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
  • Any level of Personalization
REQUEST A FREE CUSTOMIZATION
LET US HELP YOU!
  • What are the Known and Unknown Adjacencies Impacting the Sleep Apnea Devices Market
  • What will your New Revenue Sources be?
  • Who will be your Top Customer; what will make them switch?
  • Defend your Market Share or Win Competitors
  • Get a Scorecard for Target Partners
REQUEST A FREE WORKSHOP
ADJACENT MARKETS
REQUEST BUNDLE REPORTS
ONLINE CHAT
+1-888-600-6441
  • Call Us
  • +1-888-600-6441 (Corporate office hours)
  • +1-888-600-6441 (US/Can toll free)
  • +44-800-368-9399 (UK office hours)
CONNECT WITH US
ABOUT TRUST ONLINE
© MarketsandMarkets Research Private Ltd. All rights reserved